EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
EDAP (Nasdaq: EDAP) announced that CEO Ryan Rhodes and CFO Ken Mobeck will present at the Jefferies 2026 Global Healthcare Conference in New York.
Rhea-AI Summary
EDAP (Nasdaq: EDAP) announced that CEO Ryan Rhodes and CFO Ken Mobeck will present at the Jefferies 2026 Global Healthcare Conference in New York.
The presentation and 1x1 investor meetings are scheduled for Thursday, June 4, 2026, from 2:00–2:30 PM ET, with a live and archived webcast available via the Investors section of the company website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – EDAP
In the May 21 session, EDAP gained 1.88%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- June 4, 2026
- Jefferies 2026 Global Healthcare Conference presentation
- Presentation time
- 2:00–2:30 PM ET
- Jefferies 2026 Global Healthcare Conference session length
- Share price
- $4.25
- Price prior to conference announcement on May 21, 2026
- Price change 24h
- -1.62%
- Move in prior session before this news
- 52-week range
- $1.21–$5.05
- Distance of current price from recent extremes
- Market cap
- $165,670,378
- Equity value before Jefferies conference update
- 200-day MA
- $3.06
- Pre-news long-term moving average level
- Volume today
- 37,049 shares
- Trading volume vs 20-day average of 37,897 shares
Historical Context
-
Non-binding LOI with Telix for joint HIFU and PSMA PET initiatives.
-
Announcement of June 1 Investor Day focused on growth strategy and targets.
-
Record Q1 2026 HIFU revenue and strong system sales growth.
-
HIFI-2 salvage HIFU data with favorable ADT-free survival and safety.
-
Scheduling announcement for Q1 2026 results call and webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
Company to Present and Host 1x1 Investor Meetings on Thursday, June 4th, 2026
AUSTIN, Texas, May 21th, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1x1 investor meetings at the upcoming Jefferies 2026 Global Healthcare Conference in New York.
Date: Thursday, June 4th
Time: 2:00-2:30 PM ET
Format: Presentation and 1x1 investor meetings
Webcast: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/mNTgvmem3UJgTk2XzExVDK
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.